YUHSpace: Dept. of Radiation Oncology (방사선종양학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Radiation Oncology (방사선종양학교실)

Dept. of Radiation Oncology (방사선종양학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Vers...

Jang, Jin-Young ; Han, Youngmin ; Lee, Hongeun ; Kim, Sun-Whe ; Kwon, Wooil ;... ANNALS OF SURGERY, Vol.268(2) : 215-222, 2018

Phase II trial of concurrent radiation and weekly cisplatin followed by ...

Seok Jin Kim ; Kihyun Kim ; Byung Soo Kim ; Chul Yong Kim ; Cheolwon Suh ; Jo... JOURNAL OF CLINICAL ONCOLOGY, Vol.27(35) : 6027-6032, 2009

PDF

Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Th...

Ann H. Klopp ; Anamaria R. Yeung ; Snehal Deshmukh ; Karen M. Gil ; Lari Wenz... JOURNAL OF CLINICAL ONCOLOGY, Vol.36(24) : 2538-2544, 2018

This table browses all dspace content
Issue Date	Title	Journal Title
2026	Real-time prediction of breast cancer sites using deformation-aware graph neural network	Engineering Applications of Artificial Intelligence
2025	The concept, intention, and evaluation of the term treatment-refractory meningioma	JOURNAL OF NEURO-ONCOLOGY
2025	Comparative evaluation of volume and helical four‐dimensional computed tomography using canon system	JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS
2025	A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma	ORAL ONCOLOGY
2025	Improving mortality prediction after radiotherapy with large language model structuring of large-scale unstructured electronic health records	RADIOTHERAPY AND ONCOLOGY
2025	4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy	Cell reports. Medicine
2025	Targeting ataxia-telangiectasia mutated and cystine/glutamate antiporter enhances radiotherapy efficacy and tumor suppression in glioblastoma	JOURNAL OF NEURO-ONCOLOGY
2025	End-to-end breast cancer radiotherapy planning via LMMs with consistency embedding	MEDICAL IMAGE ANALYSIS
2025	Spatial Dose-Response Pattern Associated With Severe Radiation-Induced Lymphopenia in the Liver: A Voxel-Based Analysis	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2025	Stereotactic Ablative Radiotherapy versus Surgery in Patients with Pulmonary Metastases from Colorectal Cancer	CANCER RESEARCH AND TREATMENT
2025	Outcomes of Stereotactic Body Radiation Therapy for Large Uveal Melanoma: A Retrospective Analysis of Asian Population	CANCER RESEARCH AND TREATMENT
2025	Tissue-specific iron levels modulate lipid peroxidation and the FLASH radiotherapy effect	CELL DEATH & DISEASE
2025	A volumetric modulated arc therapy-based dynamic conformal arc technique with limited monitor units (VMATliMU) to reduce multileaf collimator interplay effects: A computational phantom study for stage I non-small-cell lung cancer	PLOS ONE
2025	Label-independent framework for objective evaluation of cosmetic outcome in breast cancer	ARTIFICIAL INTELLIGENCE IN MEDICINE
2025	Design and validation of a real-breath-sound-guided laser system for improved respiratory regularity in radiotherapy	JOURNAL OF THE KOREAN PHYSICAL SOCIETY
2025	Improving segmentation precision in prostate cancer adaptive radiation therapy with a patient-specific network	PLOS ONE
2025	Patterns of Initial Lymph Node Involvement and Recurrence in Patients With Maxillary Sinus Squamous Cell Carcinoma	HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2025	Feasibility study of dose de-escalation in postoperative intensity-modulated radiation therapy for locally advanced thymoma	RADIATION ONCOLOGY JOURNAL
2025	The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment	LANCET
2025	Radiotherapy quality assurance program of ongoing clinical trial using stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a dummy run study of a prospective, randomized, multicenter phase III trial (KGOG 3064/KROG 2204)	BMC CANCER